{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:23:13Z","timestamp":1772104993734,"version":"3.50.1"},"reference-count":29,"publisher":"Journal of Biomedical Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2021]]},"DOI":"10.7555\/jbr.34.20200057","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T01:00:35Z","timestamp":1608512435000},"page":"61","source":"Crossref","is-referenced-by-count":11,"title":["Valproic acid therapy decreases serum 25-hydroxyvitamin D level in female infants and toddlers with epilepsy\u2014 a pilot longitudinal study"],"prefix":"10.7555","volume":"35","author":[{"given":"Jinchun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zejun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4380","reference":[{"key":"key-10.7555\/JBR.34.20200057-1","doi-asserted-by":"publisher","unstructured":"Wrzosek M, \u0141ukaszkiewicz J, Wrzosek M, et al.  Vitamin D and the central nervous system[J]. <i>Pharmacol Rep, <\/i>2013, 65(2): 271\u2013278.","DOI":"10.1016\/S1734-1140(13)71003-X"},{"key":"key-10.7555\/JBR.34.20200057-2","doi-asserted-by":"publisher","unstructured":"Borowicz KK, Morawska M, Furmanek-Karwowska K, et al.  Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock[J]. <i>Eur J Pharmacol, <\/i>2007, 573(1\u20133): 111\u2013115.","DOI":"10.1016\/j.ejphar.2007.07.002"},{"key":"key-10.7555\/JBR.34.20200057-3","doi-asserted-by":"publisher","unstructured":"Miratashi Yazdi SA, Abbasi M, Miratashi Yazdi SM.  Epilepsy and vitamin D: a comprehensive review of current knowledge[J]. <i>Rev Neurosci, <\/i>2017, 28(2): 185\u2013201.","DOI":"10.1515\/revneuro-2016-0044"},{"key":"key-10.7555\/JBR.34.20200057-4","doi-asserted-by":"publisher","unstructured":"Procopio M, Marriott PK, Davies RJE.  Seasonality of birth in epilepsy: a southern Hemisphere study[J]. <i>Seizure, <\/i>2006, 15(1): 17\u201321.","DOI":"10.1016\/j.seizure.2005.10.001"},{"key":"key-10.7555\/JBR.34.20200057-5","doi-asserted-by":"publisher","unstructured":"Shellhaas RA, Barks AK, Joshi SM.  Prevalence and risk factors for vitamin D insufficiency among children with epilepsy[J]. <i>Pediatr Neurol, <\/i>2010, 42(6): 422\u2013426.","DOI":"10.1016\/j.pediatrneurol.2010.03.004"},{"key":"key-10.7555\/JBR.34.20200057-6","doi-asserted-by":"publisher","unstructured":"Bergqvist AGC, Schall JI, Stallings VA.  Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet[J]. <i>Epilepsia, <\/i>2007, 48(1): 66\u201371.","DOI":"10.1111\/j.1528-1167.2006.00803.x"},{"key":"key-10.7555\/JBR.34.20200057-7","doi-asserted-by":"publisher","unstructured":"Turan MI, Cayir A, Ozden O, et al.  An examination of the mutual effects of valproic acid, carbamazepine, and phenobarbital on 25-hydroxyvitamin D levels and thyroid function tests[J]. <i>Neuropediatrics, <\/i>2014, 45(1): 16\u201321.","DOI":"10.1055\/s-0033-1349226"},{"key":"key-10.7555\/JBR.34.20200057-8","doi-asserted-by":"publisher","unstructured":"Verrotti A, Agostinelli S, Coppola G, et al.  A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy[J]. <i>Eur J Neurol, <\/i>2010, 17(2): 232\u2013237.","DOI":"10.1111\/j.1468-1331.2009.02773.x"},{"key":"key-10.7555\/JBR.34.20200057-9","doi-asserted-by":"publisher","unstructured":"Xu ZJ, Jing X, Li GZ, et al.  Valproate decreases vitamin D levels in pediatric patients with epilepsy[J]. <i>Seizure, <\/i>2019, 71: 60\u201365.","DOI":"10.1016\/j.seizure.2019.06.009"},{"key":"key-10.7555\/JBR.34.20200057-10","doi-asserted-by":"publisher","unstructured":"Fong CY, Kong AN, Poh BK, et al.  Vitamin D deficiency and its risk factors in Malaysian children with epilepsy[J]. <i>Epilepsia, <\/i>2016, 57(8): 1271\u20131279.","DOI":"10.1111\/epi.13443"},{"key":"key-10.7555\/JBR.34.20200057-11","doi-asserted-by":"publisher","unstructured":"Geng XJ, Kang X, Wong PCM.  Autism spectrum disorder risk prediction: A systematic review of behavioral and neural investigations[J]. <i>Prog Mol Biol Transl Sci, <\/i>2020, 173: 91\u2013137.","DOI":"10.1016\/bs.pmbts.2020.04.015"},{"key":"key-10.7555\/JBR.34.20200057-12","doi-asserted-by":"publisher","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline[J]. <i>J Clin Endocrinol Metab, <\/i>2011, 96(7): 1911\u20131930.","DOI":"10.1210\/jc.2011-0385"},{"key":"key-10.7555\/JBR.34.20200057-13","doi-asserted-by":"publisher","unstructured":"Guo HL, Jing X, Sun JY, et al.  Valproic acid and the liver injury in patients with epilepsy: an update[J]. <i>Curr Pharm Des, <\/i>2019, 25(3): 343\u2013351.","DOI":"10.2174\/1381612825666190329145428"},{"key":"key-10.7555\/JBR.34.20200057-14","doi-asserted-by":"publisher","unstructured":"Borusiak P, Langer T, Heruth M, et al.  Antiepileptic drugs and bone metabolism in children: data from 128 patients[J]. <i>J Child Neurol, <\/i>2013, 28(2): 176\u2013183.","DOI":"10.1177\/0883073812443005"},{"key":"key-10.7555\/JBR.34.20200057-15","doi-asserted-by":"publisher","unstructured":"Kim SH, Lee JW, Choi KG, et al.  A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy[J]. <i>Epilepsy Behav, <\/i>2007, 10(2): 291\u2013295.","DOI":"10.1016\/j.yebeh.2006.11.007"},{"key":"key-10.7555\/JBR.34.20200057-16","doi-asserted-by":"publisher","unstructured":"Dur\u00e1-Trav\u00e9 T, Gallinas-Victoriano F, Malumbres-Chac\u00f3n M, et al.  Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy[J]. <i>Epilepsy Res, <\/i>2018, 139: 80\u201384.","DOI":"10.1016\/j.eplepsyres.2017.11.013"},{"key":"key-10.7555\/JBR.34.20200057-17","unstructured":"Chaudhuri JR, Mridula KR, Rathnakishore C, et al.  Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients[J]. <i>Iran J Child Neurol, <\/i>2017, 11(2): 48\u201356."},{"key":"key-10.7555\/JBR.34.20200057-18","doi-asserted-by":"publisher","unstructured":"Poh BK, Ng BK, Siti Haslinda MD, et al.  Nutritional status and dietary intakes of children aged 6 months to 12 years: findings of the Nutrition Survey of Malaysian Children (SEANUTS Malaysia)[J]. <i>Br J Nutr, <\/i>2013, 110(S3): S21\u2013S35.","DOI":"10.1017\/S0007114513002092"},{"key":"key-10.7555\/JBR.34.20200057-19","doi-asserted-by":"publisher","unstructured":"Lee SH, Yu J.  Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up[J]. <i>Ann Pediatr Endocrinol Metab, <\/i>2015, 20(4): 198\u2013205.","DOI":"10.6065\/apem.2015.20.4.198"},{"key":"key-10.7555\/JBR.34.20200057-20","doi-asserted-by":"publisher","unstructured":"Yetley EA.  Assessing the vitamin D status of the US population[J]. <i>Am J Clin Nutr, <\/i>2008, 88(2): 558S\u2013564S.","DOI":"10.1093\/ajcn\/88.2.558S"},{"key":"key-10.7555\/JBR.34.20200057-21","doi-asserted-by":"publisher","unstructured":"Nettekoven S, Str\u00f6hle A, Trunz B, et al.  Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy[J]. <i>Eur J Pediatr, <\/i>2008, 167(12): 1369\u20131377.","DOI":"10.1007\/s00431-008-0672-7"},{"key":"key-10.7555\/JBR.34.20200057-22","doi-asserted-by":"publisher","unstructured":"Lee YJ, Park KM, Kim YM, et al.  Longitudinal change of vitamin D status in children with epilepsy on antiepileptic drugs: prevalence and risk factors[J]. <i>Pediatr Neurol, <\/i>2015, 52(2): 153\u2013159.","DOI":"10.1016\/j.pediatrneurol.2014.10.008"},{"key":"key-10.7555\/JBR.34.20200057-23","doi-asserted-by":"publisher","unstructured":"Yildiz EP, Poyrazoglu \u015e, Bektas G, et al.  Potential risk factors for vitamin D levels in medium- and long-term use of antiepileptic drugs in childhood[J]. <i>Acta Neurol Belg, <\/i>2017, 117(2): 447\u2013453.","DOI":"10.1007\/s13760-017-0775-x"},{"key":"key-10.7555\/JBR.34.20200057-24","doi-asserted-by":"publisher","unstructured":"Wimalawansa SJ.  Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome[J]. <i>J Steroid Biochem Mol Biol, <\/i>2018, 175: 177\u2013189.","DOI":"10.1016\/j.jsbmb.2016.09.017"},{"key":"key-10.7555\/JBR.34.20200057-25","doi-asserted-by":"publisher","unstructured":"Romoli M, Mazzocchetti P, D'Alonzo R, et al.  Valproic acid and epilepsy: from molecular mechanisms to clinical evidences[J]. <i>Curr Neuropharmacol, <\/i>2019, 17(10): 926\u2013946.","DOI":"10.2174\/1570159X17666181227165722"},{"key":"key-10.7555\/JBR.34.20200057-26","doi-asserted-by":"publisher","unstructured":"Thiel R.  Might calcium disorders cause or contribute to myoclonic seizures in epileptics?[J]. <i>Med Hypotheses, <\/i>2006, 66(5): 969\u2013974.","DOI":"10.1016\/j.mehy.2005.11.018"},{"key":"key-10.7555\/JBR.34.20200057-27","doi-asserted-by":"publisher","unstructured":"McGrath JJ, F\u00e9ron FP, Burne THJ, et al.  Vitamin D<sub>3<\/sub>\u2014implications for brain development[J]. <i>J Steroid Biochem Mol Biol, <\/i>2004, 89\u201390: 557\u2013560.","DOI":"10.1016\/j.jsbmb.2004.03.070"},{"key":"key-10.7555\/JBR.34.20200057-28","doi-asserted-by":"publisher","unstructured":"Bivona G, Agnello L, Bellia C, et al.  Non-skeletal activities of vitamin D: from physiology to brain pathology[J]. <i>Medicina (Kaunas), <\/i>2019, 55(7): 341.","DOI":"10.3390\/medicina55070341"},{"key":"key-10.7555\/JBR.34.20200057-29","doi-asserted-by":"publisher","unstructured":"Grecksch G, R\u00fcthrich H, H\u00f6llt V, et al.  Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats[J]. <i>Psychoneuroendocrinology, <\/i>2009, 34(Suppl 1): S258\u2013S264.","DOI":"10.1016\/j.psyneuen.2009.07.004"}],"container-title":["The Journal of Biomedical Research"],"original-title":[],"link":[{"URL":"http:\/\/www.jbr-pub.org.cn\/fileSWYXYJZZYWB\/journal\/article\/swyxyjzzywb\/2021\/1\/JBR-2020-0057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T17:16:09Z","timestamp":1678382169000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.34.20200057?viewType=HTML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["JBR-2020-0057"],"URL":"https:\/\/doi.org\/10.7555\/jbr.34.20200057","relation":{},"ISSN":["1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}